The aim of the present study was to measure the serum concentrations of specific cartilage and bone biomarkers reflecting tissue turnover, particularly hyaluronic acid and cartilage oligomeric matrix protein, to investigate disease activity. The study included 60 patients of rheumatoid arthritis with age range 43-66 years; thirty patients were rapid erosive patients and thirty were slow erosive, compared to twenty matched normal population with age range 46-63 years. All individuals enrolled in the study were subjected to full history taking, clinical examination and necessary laboratory investigation. The study showed significantly (P<0.0001) higher values of hyaluronic acid, cartilage oligomeric matrix protein and erythrocyte sedimentation rate in slow and rapid erosive arthritic patients versus the controls. A significant positive correlation between serum levels of tests, which have been used in this study. Also, there was a significant positive correlation between serum levels of acid and cartilage oligomeric matrix protein (r =0.788, P<0.0001), the test sensitivity was 82.5% and specificity was 100% at a cutoff point (79.5 ng/ml) for serum levels of arthritis in arthritic patients, while, the test sensitivity was 94.4% and specificity was 100% at a cutoff point (20.5 ìg/ml) for serum levels of cartilage oligomeric matrix protein in arthritic patients. The measurement of some serological biomarkers as hyaluronic acid and cartilage oligomeric matrix protein that reflect bone and cartilage destruction in arthritic patients could be used to investigate disease activity and increase the knowledge of the basic pathophysiology of joint disease.
INTRODUCTION
Arthritis is a long standing debilitating disorder that results in severe pain, impairment and disability among patients having injury to the cartilage, synovium, and bone of the affected joints 1 . Existing methods to diagnose and monitor the disease are based on late clinical manifestations of ar thritis. However, recent development of successful treatments for rheumatoid arthritis (RA) and osteoarthritis has made it imperative to identify prognostic factors disease. Therefore, the treatments can be started rapidly in order to slow down the progression of the disease 1 .
A possible approach to monitor arthritis is the estimation of biomarkers of cartilage repair and degradation to reflect variations in joint remodeling.
One such potential biomarker is cartilage oligomeric matrix protein (COMP) 2 , which is also known as thrombospondin 5. It is 524 kDa homopentameric extracellular matrix glycoprotein member of the thrombospondin family of calcium binding proteins with five identical subunits 3 . The function of COMP remains unclear; however, it may have a structural role in endochondral ossification and in the assembly and stabilization of extracellular matrix by its interaction with collagen fibrils and matrix components 4 . COMP was initially detected in serum and synovial fluid of patients suffering from rheumatoid disorders, such as RA, reactive arthritis, juvenile chronic arthritis and osteoarthritis (OA) 5 . Serum concentrations of COMP are initially elevated in patients with early RA who later develop extensive joint destruction, which suggested that the disease pathogenesis is characterized by abnormal turnover of that protein in these patients 6 .
Hyaluronic acid (HA), is a glycosaminoglycan formed from alternating units of N-acetyl glucosamine and glucuronic acid 7 . It is a constituent of synovium and cartilage and is thought to contribute to the lubricating mechanisms of synovial fluid. Local increased production of HA has been demonstrated in inflamed synovium from patients with RA, OA reactive arthritis, and ankylosing spondylitis 8 . Serum levels of HA have to be increased in individuals with liver disease 9 , cancer 10 , hypothyroidism 11 , psoriasis with or without arthropathy 12 . Thus, the aim of the study is to measure the serum concentrations of specific cartilage and bone molecules reflecting tissue turnover, as HA and COMP to investigate disease activity.
MATERIALS AND METHODS
The study included 80 human subjects; they were classified into 2 main groups. Group A included 60 RA patients attending Orthopedic Surgery Department, Al-Karak Governmental Hospital, who all fulfilled the American College of Rheumatology 1987 criteria for RA [13] , with age range 43-66 years; it included 32 females and 28 males. The median disease duration is 2.67 years (range 1-5 years), disease onset was defined as the time of onset of joint symptoms according to history at the initial visit to the Orthopedic Surgery Department outpatient Clinic. This group was subdivided into two subgroups according to radiographic examination using the Larsen method according to Petterson [14] . Group A1 included 30 patients who showed significant erosive disease of the knee joints (rapid erosive group). Group A2 included 30 patients without rapidly progressive disease (slow erosive group). Group B has included 20 healthy volunteers. The informed written consent was obtained from each patient and each subject of the control group. The experiments were conducted according to the ethical forms approved by the Faculty of Medicine Ethics Committee in Mutah University.
Medical history and clinical examination of all patients and controls were obtained. The following manifestations were recorded for each one of the RA patients: number of swollen joints, number of tender joints, patient's assessment of pain on a visual analogue scale (VAS) and patient's assessment of disease activity on a VAS. Disease activity score (DAS) were calculated with assessment of swollen and tender joints using 28-points joint counts [15] . Patients with liver diseases, hypothyroidism, chronic renal diseases, OA and psoriasis were excluded from the study.
Hands, wrists and feet of the 30 RA patients were examined radiographically and graded using Larsen method; according to Petterson [14, 16] , without the knowledge of their clinical data. That method is based on comparisons with standard radiographs, where 0 denotes a radiographically normal joint and 5 denotes the one with maximum degree of joint destruction. A theoretical range of values from 0 to 200 were used to grade these joints. All of the following laboratory investigations were obtained, including serum levels of COMP, HA, ultrasensitive C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) and the determination of rheumatoid factor titer.
5 ml of venous blood was collected from each fasting participant in the study in a plain tube and serum was separated in aliquots after centrifugation and stored at -70 o C for analysis of the following parameters: 1.
HA The obtained data was analyzed using SPSS 16 software package. Differences between groups were calculated by Mann-Whitney's test for unpaired variables. Data were expressed as mean±SD. Differences between the three groups were compared by means of ANOVA test.
Correlations were calculated by Spearman's correlation coefficient. P values <0.05 were considered significant. Assessment of optimal cutoff points was made using receiver operating characteristic curve (ROC) 21 .
RESULTS
There are significantly higher values of HA, COMP, CRP and ESR in the group of RA patients (rapid and slow erosive) when compared to the controls (Table 1 ). There are no significant differences in the number of patients, gender, the duration of RA disease, DAS and RF status between group A1 and A2 (Table 2) . However, there is a statistically significant difference regarding the age of the patients between the two groups. Additionally, patients who had rapid erosion (group A1) have a significant higher Larsen score than those with the slow erosion (group A2). There are significantly higher values of HA, COMP, CRP and ESR in the slow erosive group of RA patients (group A2) when compared to the controls (Table 3) . HA, COMP, CRP and ESR showed significant increase in the rapid erosive group of RA patients (group A1) when compared to the controls (Table 4) . When comparing HA, COMP, CRP and ESR in the rapid erosive group of RA patients (group A1) and the slow erosive group of RA patients (group A2) they showed significant increase Table  5 ). There are significant positive correlations between serum levels of HA, COMP with the age, disease duration, Larsen score, DAS, CRP and ESR (Table 6 ). There was a significant positive correlation between serum levels of HA and COMP (r= 0.788, P<0.0001) ( Table 7 and Figure 1 ). As shown in Table 8 the sensitivity and specificity test for serum COMP levels were 94.4% and 100%, respectively, at cutoff value of (20.5 µg/ml), while, they were 82.5% and 100%, respectively for serum levels of HA at cutoff value of (79.5 ng/ml) (Figure 2  and 3 ).
DISCUSSION
It is unclear that joint destruction, which is the main character of RA, progresses slowly in some patients and causes little tissue derangement; whereas in other cases, extensive destruction occurs within a few years after the disease onset 22 .
However, the present study demonstrated that there are no significant differences in the number of patients, gender, duration of RA, DAS and RF status in the rapid erosive and slow erosive patient groups. On the contrary, there is a significant difference concerning the age of patients. Also, the patients who had rapid erosion have a significant higher Larsen score than the patients with slow erosive changes. On the other hand, Majeed et al. 23 and Young et al. 24 have reported that there were no significant differences in gender, age of the patients, disease duration, RF positivity and DAS.
The use of immunoassays for the quantification of cartilage and bone molecules, which enters the circulation as part of tissue turnover that occur in RA has reflected the changes in metabolism of extracellular matrix in these tissues 22 . The obtained results in this study showed a significant increase in serum levels of HA in RA patients compared to the control group, the test sensitivity was 82.5% and specificity was 100% at a cutoff point (79.5 ng/ml), the levels of HA were significantly higher in the rapid erosive group of patients than in the slow erosive group, these results were in agreement with those of Majeed et al. 23 and Santos et al. 25 , who suggested that an increased systemic level might act as an early indicator of structural damage and hence provide a useful prognostic marker. It was reported that HA is produced locally by cells of the extracellular matrix 26 , the degeneration and turnover of the extracellular matrix result in release of HA and HA fragments into the systemic circulation. Increased production and release of HA from arthritis joints are thought to reflect the localized inflammation of the synovial lining and, to a lesser extent, to cartilage degradation. Furthermore, it has been postulated that the levels of HA were higher in RA patients than in asymptomatic donors 27 . These results also, go with those of Pothacharoen et al 28 who suggested that RA may be detected systemically according to these results.
As illustrated above, RA patients showed a significant increase in the levels of COMP compared to the controls, the test sensitivity was 94.4% and specificity was 100% at a cutoff value of (20.50 ìg/ml). Additionally, the estimation of serum COMP showed significant higher levels in the rapid erosive group compared to the slow erosive group of patients; which agrees with the results obtained by both Poole 29 and Bengt et al.
22
. Increased levels of COMP in RA could be used as a potential marker for measuring articular cartilage damage 5 or it could reflect cartilage turnover [4, 31] . Similarly, Syversen et al 2 have reported that COMP and other cartilage and bone biomarkers will serve as more useful prognostic markers than current predictors such as anti-cyclic citrullinated peptide (ACCP), early radiologic damage in the disease course, and signs of inflammation.
CRP and ESR were increased in RA patients compared to controls, and they were significantly higher in the rapid erosive group of patients versus the slow erosive group. In the present study, significant correlations between serum levels of HA and age of the patients at disease onset, disease duration, DAS and Larsen score were detected and found in accordance with those obtained by Emlen et al. 32 . Also, a significant positive correlation was detected between serum levels of HA and the levels of CRP and ESR, which supported the correlation between joint and systemic inflammation. Majeed et al. 23 demonstrated that HA serum levels are correlated with measures of disease activity including swollen joint count, tender joint count and pain VAS. However there is a strong positive correlation with laboratory indices of disease activity (ESR and CRP) rather than with the clinical indices of the disease.
The findings in our results detected, significant correlations between serum levels of COMP and age of the patient at the time onset of the disease, disease duration, DAS and Larsen score. A high clinical disease activity (DAS) was correlated with high COMP values in serum and synovial fluid and with increasing proteolytic activity 33, 34 ; the increase in turnover of cartilage matrix in joint inflammation may explain that correlation. These results were in consistence with those obtained by Skoumal et al 31 and De Jong et al 35 who found positive correlations between serum levels of COMP and Larsen score & DAS.
COMP was correlated with the radiographic progression, progressed radiographically RA showed elevated serum levels of COMP compared to those where the disease remain radiographically stable 36 , The present findings showed significant positive correlations between serum levels of COMP and the levels of CRP and ESR, those results go with those of Momohara, et al 37 , Soderlin et al 38 and Fujikawa et at 39 , who reported that serum levels of COMP correlated with ESR and CRP, which are indicators of the acute phase response. These findings have suggested that serum levels of COMP may reflect cartilage destruction. Serum COMP was found to be a specific marker for the cartilage degradation in RA and not related to the nonspecific inflammatory processes, as there was a significant difference in the levels of COMP when compared to the patients with other inflammatory rheumatic diseases with less cartilage-destructive arthritis 40 . Moreover, in the present study, the obtained results revealed a significant positive correlation between serum levels of HA and COMP.
It could be concluded that the measurement of some serological biomarkers as HA and COMP that reflect bone and cartilage destruction in RA patients, could be used to investigate disease activity and increase the knowledge of the basic pathophysiology of joint disease. It can be predicted that the possibility of evaluating HA and COMP serum levels, commonly used as routine laboratory investigations, is helpful to estimate their clinical utility as prognostic biomarkers and monitor the response to therapy among RA patients.
